Let's put that into perspective. It's only $2.5M which has probably already been spent and sitting with bills due. Next, Binder will pay for all the rest to develop, run trials, manufacture, etc. How long will that take? So NGIO gets nothing more until things progress pretty far along.
This is all a distraction. We need GNBT revenue producing companies that were bought to step up and produce revenue. We are all hoping, me included, that the NGIO listing is going to bail us all out. But what happened to GNBT's businesses? Something is broken and upper management needs to fix it FAST.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.